Literature DB >> 11287691

Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women.

B H van Benthem1, J Spaargaren, J A van Den Hoek, J Merks, R A Coutinho, M Prins.   

Abstract

OBJECTIVES: To investigate the prevalence and risk factors of HSV-1 and HSV-2 antibodies in HIV infected women and the association between recurrent genital ulcerations and HIV disease progression in HSV-2 positive women.
METHODS: The presence of HSV antibodies was tested in 276 of the 487 women participating in a European cohort study of HIV infected women. Prevalence rate ratios described the association between HSV infection and its risk factors, using log binomial regression. Generalised estimating equations (GEE) analysis was performed to determine the impact of markers of HIV disease progression on recurrent genital ulcerations.
RESULTS: The prevalence of HSV-1 and HSV-2 antibodies was 76% (95% confidence interval (95% CI): 71-81) and 42% (95% CI: 36-50); 30% (95% CI: 24-35) of the women had antibodies against both HSV-1 and HSV-2. The prevalence of HSV-1 was 86% (95% CI: 80-92) in southern Europe compared with 69% (95% CI: 57-79) and 67% (95% CI: 55-77) in central and northern Europe (p=0.002). This geographical variation remained after adjustment for other risk factors. An increasing number of years of sexual activity (p=0.0002) and a history of prostitution (p=0.0001) were independently associated with HSV-2 prevalence. In HSV-2 positive women, symptomatic cases of HSV infection were minimal, but increased with decreasing CD4 count.
CONCLUSION: In HIV infected women, the prevalence of HSV antibodies is high and symptomatic cases of HSV infection are minimal, but increase with decreasing CD4 count. HSV-2 but not HSV-1 was related to sexual behaviour (that is, a history of prostitution and the number of sexually active years) in this group of HIV infected women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287691      PMCID: PMC1744291          DOI: 10.1136/sti.77.2.120

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  27 in total

1.  Genital herpes simplex virus type 2 shedding is increased in HIV-infected women in Africa.

Authors:  F X Mbopi Keou; G Grésenguet; P Mayaud; H A Weiss; R Gopal; D W Brown; R J Hayes; D C Mabey; L Bélec
Journal:  AIDS       Date:  1999-03-11       Impact factor: 4.177

2.  A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection.

Authors:  J J Gibson; C A Hornung; G R Alexander; F K Lee; W A Potts; A J Nahmias
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

3.  Prevalence proportion ratios: estimation and hypothesis testing.

Authors:  T Skov; J Deddens; M R Petersen; L Endahl
Journal:  Int J Epidemiol       Date:  1998-02       Impact factor: 7.196

4.  Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors.

Authors:  M J van de Laar; F Termorshuizen; M J Slomka; G J van Doornum; J M Ossewaarde; D W Brown; R A Coutinho; J A van den Hoek
Journal:  Int J Epidemiol       Date:  1998-02       Impact factor: 7.196

5.  Sexually transmitted infections in European HIV-infected women: incidence in relation to time from infection. European Study on the Natural History of HIV Infection in Women.

Authors:  B H van Benthem; M Prins; C Larsen; M C Delmas; J B Brunet; A van den Hoek
Journal:  AIDS       Date:  2000-03-31       Impact factor: 4.177

6.  Analysis of herpes simplex virus 1 and 2 infection in women with high risk sexual behaviour in Mexico.

Authors:  C J Conde-Glez; L Juárez-Figueroa; F Uribe-Salas; P Hernández-Nevárez; D S Schmid; E Calderón; M Hernández-Avila
Journal:  Int J Epidemiol       Date:  1999-06       Impact factor: 7.196

7.  Comparison of a monoclonal antibody-blocking enzyme-linked immunoassay and a strip immunoblot assay for identifying type-specific herpes simplex virus type 2 serological responses.

Authors:  G J Van Doornum; M J Slomka; M Buimer; J Groen; J A Van den Hoek; I Cairo; A Vyse; D W Brown
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

8.  Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections.

Authors:  M K Breinig; L A Kingsley; J A Armstrong; D J Freeman; M Ho
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

9.  A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States.

Authors:  R E Johnson; A J Nahmias; L S Magder; F K Lee; C A Brooks; C B Snowden
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

10.  Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania.

Authors:  A Obasi; F Mosha; M Quigley; Z Sekirassa; T Gibbs; K Munguti; J Todd; H Grosskurth; P Mayaud; J Changalucha; D Brown; D Mabey; R Hayes
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

View more
  6 in total

1.  Seroepidemiology of herpes simplex virus type 2 (HSV2) in HIV infected patients in Kermanshah-Iran.

Authors:  Alireza Janbakhash; Feizollah Mansouri; Siavash Vaziri; Babak Sayad; Mandana Afsharian; Ahmadreza Abedanpor
Journal:  Caspian J Intern Med       Date:  2012

2.  Left out but not forgotten: Should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV?

Authors:  Darrell H S Tan; Rupert Kaul; Sharon Walsmley
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

3.  Seroprevalence of HSV-1 and HSV-2 in Barbados.

Authors:  P N Levett
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

4.  Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA.

Authors:  Qin Yan; Wan Li; Qiao Tang; Shuihong Yao; Zhigang Lv; Ninghan Feng; Xinting Ma; Zhiqiang Bai; Yi Zeng; Di Qin; Chun Lu
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

5.  Dendrimers functionalized with membrane-interacting peptides for viral inhibition.

Authors:  Rossella Tarallo; Tom P Carberry; Annarita Falanga; Mariateresa Vitiello; Stefania Galdiero; Massimiliano Galdiero; Marcus Weck
Journal:  Int J Nanomedicine       Date:  2013-02-05

6.  Nested PCR for detection of HSV-1 in oral mucosa.

Authors:  Miranda-Masoumeh Jalouli; Jamshid Jalouli; Bengt Hasséus; Jenny Öhman; Jan-Michaél Hirsch; Lars Sand
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.